A Randomized Trial Comparing Fluconazole with Clotrimazole Troches for the Prevention of Fungal Infections in Patients with Advanced Human Immunodeficiency Virus Infection

New England Journal of Medicine

Volumn 332, Issue 11, 1995, Pages 700-705

  Powderly, William G ^a   Finkelstein, Dianne M ^b   Feinberg, Judith ^c   Frame, Peter ^d   He, Weili ^b   Van Der Horst, Charles ^e   Koletar, Susan L ^f   Eyster, M Elaine ^g   Carey, John ^h   Waskin, Hetty ⁱ   Hooton, Thomas M ^j   Hyslop, Newton ^k   Spector, Stephen A ^l   Bozzette, Samuel A ^l  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d UNIVERSITY OF CINCINNATI   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g PENN STATE COLLEGE OF MEDICINE   (United States)

^h CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ DUKE UNIVERSITY   (United States)

^j UNIVERSITY OF WASHINGTON   (United States)

^k TULANE UNIVERSITY   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BARIUM; CD4 ANTIGEN; CLOTRIMAZOLE; COTRIMOXAZOLE; DAPSONE; FLUCONAZOLE; NYSTATIN; PENTAMIDINE; POTASSIUM HYDROXIDE;

ADULT; ARTICLE; BIOPSY; CANDIDIASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRYPTOCOCCOSIS; ENDOSCOPY; ESOPHAGUS DISEASE; FEMALE; FUNGUS CULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; LIVER FUNCTION TEST; LIVER TOXICITY; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROSCOPY; MULTICENTER STUDY; MYCOSIS; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SURVIVAL;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CD4 LYMPHOCYTE COUNT; CLOTRIMAZOLE; CONFIDENCE INTERVALS; FEMALE; FLUCONAZOLE; FOLLOW-UP STUDIES; HUMANS; MALE; MYCOSES; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 0028944782     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199503163321102     Document Type: Article

References (18)

1. Leoung GS, Feigal DW, Montgomery AB, Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia.: the San Francisco community prophylaxis trial. N Engl J Med 1990; 323.: 769-775
2. Schneider MME, Hoepelman AIM, Eeftinck Schattenkerk JK, A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. N Engl J Med 1992; 327.: 1836-1841
3. Hardy WD, Feinberg J, Finkelstein DM, A controlled trial of trimethoprim-sulfamethoxazole or aerosolized pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome.: aids Clinical Trials Group protocol 021. N Engl J Med 1992; 327.: 1842-1848
4. Osmond D, Charlebois E, Lang W, Shiboski S, Moss A Changes in aids survival time in two San Francisco cohorts of homosexual men.: 1983 to 1993. JAMA 1994; 271.: 1083-1087
5. Nightingale SD, Cameron DW, Gordin FM, Two controlled trials of rifabutin prophylaxis against Mycobacterium avium complex infection in aids. N Engl J Med 1993; 329.: 828-833
6. Dismukes WE Cryptococcal meningitis in patients with aids. J Infect Dis 1988; 157.: 624-628
7. Chuck SL, Sande MA Infections with Cryptococcus neoformans in the acquired immunodeficiency syndrome. N Engl J Med 1989; 321.: 794-799
8. Bozzette SA, Larsen RA, Chiu J, A placebo-controlled trial of maintenance therapy with fluconazole after treatment of cryptococcal meningitis in the acquired immunodeficiency syndrome. N Engl J Med 1991; 324.: 580-584
9. Stevens DA, Greene SI, Lang OS Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex.: randomized, double-blind, placebo-controlled study of 100-mg oral fluconazole daily. Arch Intern Med 1991; 151.: 2458-2464
10. Just-Nubling G, Gentschew G, Meissner K, Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. Eur J Clin Microbiol Infect Dis 1991; 10.: 917-921
11. Bozzette SA, Finkelstein DM, Spector SA, A randomized trial of three antipneumocystis agents in patients with advanced human immunodeficiency virus infection. N Engl J Med 1995; 332.: 693-699
12. Powderly WG, Saag MS, Cloud GA, A controlled trial of fluconazole or amphotericin B to prevent relapse of cryptococcal meningitis in patients with the acquired immunodeficiency syndrome. N Engl J Med 1992; 326.: 793-798
13. Wheat J, Hafner RE, Wulfsohn M, Prevention of relapse of histoplasmosis with itraconazole in patients with the acquired immunodeficiency syndrome. Ann Intern Med 1993; 118.: 610-616
14. Galgiani JN, Ampel NM Coccidioidomycosis in human immunodeficiency virus-infected patients. J Infect Dis 1990; 162.: 1165-1169
15. Kobayashi GS, Travis SJ, Rinaldi MG, Medoff G In vitro and in vivo activities of Sch 39304, fluconazole, and amphotericin B against Histoplasma capsulatum. Antimicrob Agents Chemother 1990; 34.: 524-528
16. Wheat LJ, Mawhinney S, Hafner R, et al. Fluconazole treatment for histoplasmosis in AIDS.: prospective multicenter noncomparative trial. In.: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy, Orlando, Fla., Oct. 4-7, 1994. Washington, D.C.: American Society for Microbiology, 1994.:214. abstract.
17. Powderly WG Resistant candidiasis. AIDS Res Hum Retroviruses 1994; 10.: 925-929
18. Cameron ML, Schell WA, Bruch S, Bartlett JA, Waskin HA, Perfect JR Correlation of in vitro fluconazole resistance of Candida isolates in relation to therapy and symptoms of individuals seropositive for human immunodeficiency virus type 1. Antimicrob Agents Chemother 1993; 37.: 2449-2453